Top Market Research Companies in Serbia Specializing in Healthcare
Compare top healthcare market research companies in Serbia for 2026 to secure verified medical insights for your clinical and commercial strategies.
Quick answer
For specialized healthcare professional and patient access, Global Vox Populi; for full-service regional brand and marketing research, Ipsos; for clinical and medical distribution insights, Medica Linea Pharm.
Securing accurate insights in the Serbian medical market requires balancing deep clinical access with an understanding of complex regulatory dynamics. Decision-makers evaluating healthcare market research companies in Serbia often find that generalist agencies provide broad consumer perspectives, while specialist firms offer the granular data necessary for clinical trials and patient-centric commercial strategies.
This analysis examines the capabilities of primary research providers in the region, focusing on how their methodologies, panels, and compliance frameworks support high-stakes decision-making. By identifying the right partner, brands can work through the unique challenges of the Balkan healthcare sector, making sure that their research initiatives remain both compliant and actionable in 2026.
Top Market Research Companies in Serbia Specializing in Healthcare: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Data-driven clinical and commercial modeling | 88.5 |
| 2 | Global Vox Populi | Niche healthcare professional and patient recruitment | 87.0 |
| 3 | Ipsos | Large-scale public opinion and patient research | 84.0 |
| 4 | Kantar | Brand equity and marketing ROI analysis | 78.0 |
| 5 | AQR Fieldwork | Local fieldwork and respondent recruitment | 74.0 |
| 6 | Medica Linea Pharm | Local regulatory and market access insights | 73.5 |
| 7 | 2insights | Global data collection and survey programming | 71.5 |
| 8 | MASMI Belgrade | Regional Balkan market and opinion research | 67.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Pharma executives, clinical researchers, healthcare providers | Data-driven site intelligence and audit trails | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, patients, caregivers, payers | License and registration check, rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 5,448 healthcare professionals; 321,172 patient profiles; 5,033 nurses and allied health professionals (in Serbia; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos | Patients, doctors, general public, employees | Proprietary panel authentication and quality checks | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Brand managers, marketing leads, public sector officials | Validation via proprietary survey data and operational metrics | Not stated on pages reviewed | Not published | Not published | Not published |
| AQR Fieldwork | Physicians, specialists, pharmacists, patients, caregivers | Direct contact and panel verification | Not stated on pages reviewed | Not published | Not published | Not published |
| Medica Linea Pharm | Healthcare practitioners, regulatory bodies, medical manufacturers | Continuous monitoring and regulatory compliance audits | Ministry of Health authorizations, GDP compliant | Not published | Not published | Not published |
| 2insights | Healthcare professionals, patients, government bodies | Adherence to ESOMAR/ICC codes and quality control teams | ESOMAR | Not published | Not published | Not published |
| MASMI Belgrade | General public, healthcare consumers, business stakeholders | Methodological validation and internal quality control | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos | ● | ● | – | ● | – | ● |
| Kantar | ● | ● | – | ● | – | – |
| AQR Fieldwork | ● | ● | ● | ● | ● | – |
| Medica Linea Pharm | – | ● | – | ● | – | – |
| 2insights | ● | ● | – | ● | – | ● |
| MASMI Belgrade | ● | ● | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to deliver high-quality, compliant healthcare data through verified respondent access.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This evaluates the depth of experience in the Serbian medical sector, including knowledge of local therapeutic areas and the regulatory environment. High scores go to agencies that understand the nuances of the local doctor-patient relationship and the specific barriers to accessing medical stakeholders in the Balkan region. |
| Compliance, Certifications and Security | 20 | This measures adherence to ISO standards and data protection laws like GDPR and HIPAA. Strong performance requires documented processes for handling sensitive health information, managing adverse events, and maintaining strict consent protocols. A failure to show certifications or clear security frameworks significantly reduces the reliability of the research. |
| Target Audience Reach | 15 | This assesses the ability to access specific cohorts, such as hard-to-reach sub-specialists or patients with rare conditions. A high-scoring provider maintains a well-profiled, proprietary panel that allows for granular targeting based on specific clinical data points, rather than relying on generic, unverified lists or third-party recruitment. |
| Research Quality | 10 | This examines the rigour of questionnaire design, sampling strategies, and data cleaning techniques used to remove bots and fraudulent completes. Excellent providers implement multi-layered verification, including identity fingerprinting and straight-lining detection, to protect the findings represent genuine, high-quality responses from the target demographic. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This assesses the diversity of research tools available, ranging from traditional focus groups and in-depth interviews to advanced digital survey methods and mobile-assisted data collection. A broad toolkit allows the agency to match the methodology to the specific needs of the study, whether quantitative or qualitative. |
| Analytical Capability | 5 | This measures the agency's ability to synthesize data into strategic recommendations. Top firms move beyond simple reporting to provide insights on market trends, patient behavior, and competitive dynamics, directly informing the client’s business strategy or clinical development path. |
| Client Service and Speed | 5 | This evaluates responsiveness, project management, and the ability to meet tight deadlines. For healthcare studies where timing often impacts clinical trial milestones or market entry, the provider must demonstrate a clear, communication-heavy approach to managing fieldwork and addressing unexpected issues. |
| Pricing and Feasibility Transparency | 5 | This measures the clarity of feasibility estimates and cost projections provided during the initial briefing. A high-scoring firm communicates honestly about what is achievable, avoids hidden costs, and provides realistic timelines for recruitment, especially when targeting niche or small patient populations. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: market research companies in Serbia
IQVIA: best for data-driven clinical and commercial modeling
Strongest fitGlobal pharma companies needing large-scale data and clinical trial support.
IQVIA integrates data, technology, and analytics to support pharmaceutical and healthcare stakeholders. Its Serbian operations focus on improving patient outcomes through evidence-based research and clinical trial optimization.
The company provides functional service provider models that offer flexibility in R&D and commercialization. Their approach combines proprietary datasets with advanced AI to help clients work through complex, competitive environments.
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- Clinical Development: Full-service solutions for optimizing clinical trials and site identification.
- Real-World Evidence: Generating insights from non-identified patient records to improve outcomes.
- Commercial Intelligence: Strategic consulting and market analysis for pharma and pharmacy partners.
Strengths
- Data Depth: Access to petabytes of proprietary, non-identified patient data.
- Functional Outsourcing: Flexible FSP models that integrate with existing client teams.
Innovation and technology
- AI Integration: Uses IQVIA.ai and agentic platforms to accelerate decision-making.
Impact on businesses
- Asset Maximization: Improves the probability of success for pharmaceutical assets.
Why it may fit your brief
IQVIA fits well when projects require immense data modeling and global reach. Smaller, boutique studies may find more agile support from local specialized agencies.
Global Vox Populi: best for niche healthcare professional and patient recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitResearch projects requiring highly targeted, verified clinical or patient populations.
Global Vox Populi provides comprehensive primary research services through its proprietary panels, supporting complex healthcare studies in Serbia. The firm emphasizes rigorous recruitment and validation processes, protecting high-quality data collection across a wide range of therapeutic areas and professional specialties.
The agency maintains a strong presence in the market by offering healthcare market research in Serbia backed by ISO-certified infrastructure. Its model focuses on transparency and compliance, making it a suitable choice for clients requiring high-fidelity data for clinical or commercial decision-making.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Serbia
5,448 panellists
- Primary & General1,800
- Internal Medicine Subspecialties606
- Diagnostic & Laboratory450
- Acute, Peri-operative & Critical Care438
- Surgical Specialties372
- Nervous System & Mental Health332
Patient panel, in Serbia
321,172 patient profiles
- Aesthetics & Cosmetic101,603
- Cardiovascular27,837
- Ophthalmology19,024
- Endocrinology & Metabolic17,759
- Dermatology15,643
- Women's Health14,948
Across 731 conditions; a patient with more than one condition is counted once per condition.
Nurses and allied health panel, in Serbia
5,033 panellists
- Registered Nurses736
- Advanced Practice Nurses230
- Licensed / Practical / Enrolled Nurses189
- Nursing Support (Aides / HCAs)194
- Midwives199
- Pharmacists & Pharmacy Techs238
Scorecard: 87.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 87.0 |
Core services
- Proprietary Panel Access: Access to healthcare professionals and patients across 199 markets.
- Full-Service Fieldwork: End-to-end management of studies from recruitment to final reporting.
- Compliance Management: Adherence to international codes and HIPAA-compliant data handling practices.
Strengths
- Specialized Panel Reach: Maintains 5,448 healthcare professionals and 321,172 patient profiles in Serbia.
- Rigorous Data Quality: Employs identity fingerprinting and bot detection to maintain data integrity.
- Professional Validation: Rolling re-validation of clinical members against license and registration records.
Innovation and technology
- Advanced Digital Tools: Uses mobile and WhatsApp-assisted surveys for real-time data collection.
- Proprietary Platforms: Surveys are programmed and hosted on a dedicated, secure platform.
Impact on businesses
- Strategic Decision Support: Provides actionable insights for clinical development and commercial strategy.
- Compliance Assurance: Makes sure all research meets international standards for clinical data integrity.
Why it may fit your brief
The agency is well-suited for studies where data quality and compliance are essential. Other providers may be more appropriate for broad consumer-focused studies that do not require specialized medical panels.
Ipsos: best for large-scale public opinion and patient research
Strongest fitOrganizations requiring large-scale patient and healthcare system tracking.
Ipsos maintains a strong local presence in Serbia, offering comprehensive research across healthcare and public opinion. The company combines local market understanding with global analytical frameworks to deliver actionable intelligence.
Its healthcare practice focuses on patient and physician perceptions, tracking systemic quality and public health trends. The firm supports strategic decisions by using a mix of survey, social media, and qualitative data.
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Market Understanding: Provides strategic market analysis and brand health tracking.
- Doctor & Patient Research: Tracks perceptions of healthcare quality and clinical issues.
- Qualitative Research: Uses Ipsos UU for deep-dive human understanding.
Strengths
- Global Trends Access: Uses extensive global datasets to benchmark local findings.
- Integrated Data Sources: Combines survey data with social media and qualitative insights.
Innovation and technology
- Augmented Ipsos: Integrates AI to deliver faster insights for complex queries.
Impact on businesses
- Actionable Truth: Helps clients make smarter decisions in rapidly changing markets.
Why it may fit your brief
Ipsos is a strong partner for broad healthcare tracking and public policy research. It may be less focused on niche patient recruitment than specialized boutique agencies.
Kantar: best for brand equity and marketing ROI analysis
Strongest fitMarketing managers needing to evaluate brand health and campaign ROI.
Kantar uses proprietary frameworks to measure brand equity and market growth. Its Serbian office offers full-scope research services, applying behavioral economics and neuroscience to understand complex consumer and healthcare interactions.
The company provides agile platforms for rapid insights, enabling marketing teams to make evidence-based decisions. Their work across the healthcare sector focuses on patient journeys and brand positioning.
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantartns-see.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- Brand Equity Solutions: Uses the Meaningful Different Framework to measure brand growth.
- Marketing Analytics: Optimizes advertising spend and campaign effectiveness.
- Innovation Consulting: Guides product development using qualitative and quantitative data.
Strengths
- Validated Frameworks: Applies established models like BrandZ to evaluate market position.
- Agile Platforms: Kantar Marketplace delivers results in hours for rapid decision-making.
Innovation and technology
- Neuroscience Application: Uses neuroscience learnings to shape brand touchpoints.
Impact on businesses
- Growth Strategy: Identifies strategies to improve market share and brand saliency.
Why it may fit your brief
Kantar is ideal for brand-centric healthcare research. However, it may be less suitable for highly technical clinical or regulatory-focused research studies.
AQR Fieldwork: best for local fieldwork and respondent recruitment
Strongest fitClients needing reliable local recruitment and fieldwork execution.
AQR Fieldwork focuses on the practical aspects of research, specializing in identifying and contacting the right participants. Their local operations in Serbia support various methodologies including focus groups and in-depth interviews.
The company maintains a healthcare panel covering professionals from directors to nurses and patients. They are experienced in conducting research in settings where online methodologies face challenges, offering reliable face-to-face and telephonic support.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Respondent Recruitment: Recruits project-specific audiences for medical and B2B segments.
- Data Collection: Offers CATI, F2F, and online data collection services.
- Fieldwork Management: Supports IDIs, focus groups, and central location tests.
Strengths
- Niche Reach: Direct access to specialized healthcare workers and patients.
- Methodological Flexibility: Expertise in managing difficult-to-reach audiences via CATI.
Innovation and technology
- Fieldwork Agility: Adapts data collection methods to protect high completion rates.
Impact on businesses
- Actionable Insights: Delivers core data that informs business planning and strategy.
Why it may fit your brief
AQR is an excellent choice for operational fieldwork support. Clients needing full-scale strategic consultancy might pair them with a specialized analytical partner.
Medica Linea Pharm: best for local regulatory and market access insights
Strongest fitManufacturers seeking both market insights and regulatory/distribution support.
Medica Linea Pharm operates as a dedicated partner for innovative healthcare producers, combining market research with distribution capabilities. Their team provides in-depth analysis of local trends and regulatory requirements in Serbia.
The agency focuses on market access, helping clients work through the complex healthcare environment through evidence-based insights. Their work makes sure that strategic decisions are aligned with local regulatory and commercial realities.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | medicalineapharm.rs (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Market Research & Analysis: Provides in-depth insights into local healthcare market dynamics.
- Regulatory Strategy: Assists with licensing and trade requirements for new products.
- Distribution Services: Manages wholesale distribution and storage for medicinal products.
Strengths
- Regulatory Expertise: Deep knowledge of local Ministry of Health and EU GDP requirements.
- Strategic Focus: Highly selective portfolio support for innovative producers.
Innovation and technology
- Supply Chain Integration: Combines research insights with authorized supply chain monitoring.
Impact on businesses
- Safe Market Access: Protects the fastest and safest route to market for healthcare products.
Why it may fit your brief
Medica Linea is essential for market entry and regulatory navigation. It may be less focused on pure primary research or broad consumer behavioral studies.
2insights: best for global data collection and survey programming
Strongest fitClients needing rapid, global data collection across multiple sectors.
2insights delivers comprehensive research solutions, from initial concept to implementation. Their services in Serbia and globally include quantitative and qualitative data collection, supported by experienced analysts.
The company uses AI for real-time analysis and survey automation. They emphasize adherence to ESOMAR codes, protecting ethical standards across all healthcare and consumer research projects.
Scorecard: 71.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 71.5 |
Core services
- Data Collection: Provides full-service qualitative and quantitative fieldwork.
- Survey Programming: Effective programming solutions for complex research needs.
- Analytical Reporting: Synthesis of data into insights for strategic decision-making.
Strengths
- Global Reach: Executes projects across various geographies and sectors.
- Industry Expertise: Strong focus on consumer healthcare, rare diseases, and medical devices.
Innovation and technology
- AI-Driven Insights: Uses virtual moderators and chatbots for real-time engagement.
Impact on businesses
- Strategic Guidance: Assists clients in aligning business models with market needs.
Why it may fit your brief
2insights is well-suited for high-volume data collection. It may be less focused on the deeply specific, local regulatory navigation required by some clinical projects.
MASMI Belgrade: best for regional Balkan market and opinion research
Strongest fitCompanies needing regional Balkan expertise and localized insights.
MASMI Belgrade serves domestic and multinational clients by providing full-service research solutions. Their team, composed of psychologists and statisticians, emphasizes methodological rigour in solving business problems.
The agency covers healthcare and public opinion research, helping clients measure market performance and detect potential issues early through validated research techniques.
Scorecard: 67.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | masmi.rs (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 67.0 |
Core services
- Market Research: Conducts full-service quantitative and qualitative studies.
- Public Opinion Research: Measures attitudes and behaviors across the Balkan region.
- Data Processing: Expertise in data analysis and methodological consulting.
Strengths
- Regional Coverage: Deep understanding of the Balkan market environment.
- Expert Team: Staff includes psychologists and economists for holistic analysis.
Innovation and technology
- Methodological Focus: Prioritizes solid methodological foundations for problem-solving.
Impact on businesses
- Informed Decision-Making: Provides the insights necessary for secure business decisions.
Why it may fit your brief
MASMI is a strong regional partner. It may be less suitable for projects requiring specialized, large-scale international medical panels compared to global firms.
How HCP and patient verification actually works in Serbia
Rigorous validation of medical respondents is essential to prevent data fraud and protect clinical relevance.
Professional Licensing Checks
Providers must verify healthcare professionals against official national registries or medical licenses. This confirms that participants are indeed the specialists they claim to be. Ask for a description of the re-validation schedule, as licenses expire and professional status changes. A reliable agency will demonstrate a clear audit trail for these checks, often conducting them on a rolling basis to maintain the integrity of the panel database and prevent ineligible participants from entering surveys.
Digital Identity Fingerprinting
Identity fingerprinting prevents multiple accounts from being used by the same person. This technology identifies unique device characteristics and IP addresses to detect duplicate attempts at participation. In healthcare research, where incentives are often higher, this is a critical defense against fraudulent completes. Request proof of how the agency handles device-level recognition and what happens when a duplicate is identified. Avoid providers that rely solely on email verification, as this is easily bypassed by sophisticated bot activity.
Data Quality Scoring
Agencies should implement automated algorithms that detect speeding, straight-lining, and inconsistent answers within a questionnaire. For complex medical surveys, these tools make sure that respondents are truly reading the clinical scenarios presented. Ask to see sample completion-quality reports or the agency’s policy on removing low-quality responses before they reach the final dataset. A reputable partner will have clear criteria for discarding data and will provide transparency on how many completes were removed during the quality control process.
Manual Verification Processes
Beyond automated checks, human review of open-ended responses can identify inconsistencies that bots might miss. Experienced moderators or data analysts should review qualitative feedback for tone and clinical accuracy. If a respondent’s answers do not align with their stated specialty, they should be flagged for manual review or exclusion. This dual approach of technology and human oversight is the standard for high-stakes healthcare research in the Serbian market.
How to choose the right provider in Serbia
Selecting a partner requires aligning their specific research strengths with the unique needs of the Serbian medical environment.
- Define Research Objectives: Determine if the study requires deep clinical access, regulatory navigation, or broad market tracking. Choose a partner that specializes in your specific type of healthcare research.
- Verify Panel Integrity: Ask for the recruitment source of the provider's panel. Protect they use verified registries and professional communities rather than open-market lists.
- Assess Compliance Capabilities: Confirm the provider's knowledge of local Serbian healthcare laws and international data standards like GDPR. Compliance is non-negotiable for medical research.
- Request Feasibility Proof: Ask for a feasibility check early in the process. The provider should be able to tell you exactly how many qualified respondents exist for your specific criteria.
- Evaluate Analytical Depth: Review previous work or case studies to see how the agency translates raw data into business recommendations. Make sure they understand the clinical context.
Questions to ask before you commission
- How do you verify the credentials of your healthcare professional panel members in Serbia?
- What specific measures do you take to prevent fraudulent survey completes in medical studies?
- Can you provide a feasibility estimate for my target respondent population before we begin?
- How does your agency handle adverse event reporting in accordance with industry guidance?
- What is your experience working through the specific regulatory requirements for healthcare research in this country?
- How do you protect the privacy of patient data when conducting studies in the Serbian market?
Common pitfalls to avoid
- Relying on Generic Panels: Using general consumer panels for specialized medical research leads to low-quality insights and potential identity fraud.
- Ignoring Regulatory Nuance: Failing to account for local Serbian healthcare regulations can result in non-compliant research and legal issues.
- Underestimating Recruitment Time: Niche healthcare audiences are hard to reach; assuming fast, easy recruitment often leads to disappointment and project delays.
- Lack of Data Transparency: Choosing a partner that does not allow you to review their data cleaning and quality control processes creates a risk of inaccurate insights.
What a feasibility check should include
A comprehensive feasibility check must account for the specific incidence rate of the target medical condition or specialty.
Target Population Sizing
The provider should clearly state the total number of qualified respondents available. This prevents mid-project surprises where recruitment stalls due to a smaller-than-expected pool.
Incidence Rate Analysis
Ask for a realistic assessment of the incidence rate for your target group. In healthcare, low-incidence populations require longer timelines and more specialized recruitment channels.
Geographic Coverage Check
Make sure the provider can reach respondents across all relevant regions of Serbia. Relying only on Belgrade may skew your data if national healthcare trends differ.
Timeline Realism
A good feasibility report includes a honest timeline for recruitment. If a provider promises unrealistic turnaround times for hard-to-reach specialists, treat it as a red flag.
Conclusion
Choosing the right partner from among the available healthcare market research companies in Serbia depends on the nature of your project. For studies requiring highly targeted, verified clinical panels and stringent compliance, firms like Global Vox Populi offer the depth and security required. Conversely, if your needs lean toward large-scale public opinion or brand tracking, larger agencies like Ipsos or Kantar provide solid analytical frameworks and regional reach.
When selecting your partner, prioritize transparency regarding their panel recruitment and quality control processes. Use the provided scorecard to evaluate each provider based on your specific requirements, whether you are seeking market access strategy, clinical trial recruitment, or patient experience insights. By aligning these capabilities with your project goals, you protect the delivery of high-fidelity data to inform your strategic decisions in 2026.
Planning research in Serbia? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which market research companies in Serbia specialize in healthcare?
Specialized healthcare research in Serbia is provided by companies like Global Vox Populi, which maintains dedicated medical and patient panels, and Medica Linea Pharm, which focuses on regulatory and market access consulting. Other global firms like Ipsos and IQVIA also maintain strong healthcare practices, using global data and local expertise to support complex pharmaceutical and clinical studies.
How do I find reliable healthcare market research partners in Serbia?
To find a reliable partner, focus on agencies that provide evidence of rigorous respondent validation and compliance with international standards like ISO 20252. Ask prospective agencies for their feasibility study methods, their panel recruitment sources, and their experience with local healthcare regulations. Prioritize agencies that offer transparent reporting on their data quality and respondent verification procedures.
Is Serbia a good location for healthcare market research and clinical trials?
Serbia is increasingly recognized as a viable location for healthcare research and clinical trials due to its growing medical infrastructure and the availability of skilled healthcare professionals. Its regulatory environment is evolving to align with international standards, making it an attractive region for both patient-centric research and commercial market analysis, provided that partners have the necessary expertise to work through local requirements.
What are the top full-service market research agencies in Belgrade?
Belgrade hosts several full-service agencies that serve the healthcare sector, including Ipsos, which offers broad research capabilities, and MASMI Belgrade, which specializes in regional Balkan research. Global Vox Populi and 2insights also provide comprehensive, full-service support, with specialized healthcare panels and analytical tools designed for both quantitative and qualitative research needs.
How does the regulatory environment in Serbia impact healthcare market research?
The regulatory environment requires strict adherence to data protection laws, such as GDPR, and specific guidelines for handling medical data and adverse event reporting. Research agencies must be well-versed in these requirements to make sure that studies remain compliant. Partners with experience in local regulatory navigation, such as Medica Linea Pharm, are often better equipped to manage these complexities during the research process.
Are there global market research firms with offices in Serbia?
Yes, several global market research firms maintain offices in Serbia to support regional and international clients. Companies like Ipsos, Kantar, and IQVIA have established local entities that integrate global analytical frameworks with deep local market knowledge. These firms are well-positioned to handle large-scale research projects that require both international standards and local execution expertise.
What methodology is best for medical market research in the Balkans?
The best methodology depends on the objective: quantitative methods like online surveys are efficient for large samples, while qualitative methods like in-depth interviews are better for understanding physician decision-making and patient journeys. In the Balkans, a hybrid approach, combining digital survey tools with targeted, face-to-face or telephonic interviews, often yields the most reliable and actionable insights for complex medical topics.
What is the importance of proprietary panels in healthcare research?
Proprietary panels are essential in healthcare research because they allow for granular, verified targeting of specific medical specialists and patient groups. Unlike open-market lists, proprietary panels are recruited and managed by the agency, making sure that members are validated and profiled on multiple data points. This leads to higher data quality and more accurate insights for clinical and commercial decision-making.